Barclays analyst Steve Valiquette raised his price target for Align Technology to $325 ahead of the company's analyst meeting on May 23. The competing products at this month's American Association of Orthodontists tradeshow are limited in the type of malocclusions that can be treated, and many also lack supporting case management software for the orthodontist that is critical to the overall process in today's market, Valiquette tells investors in a research note. He adds that the announced pricing by competitors includes only modest discounts versus Align's Invisalign pricing. The analyst keeps an Overweight rating on Align Technology.